Ionis Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 25 analysts polled by S&P Global, Ionis Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $84.13. The average 1-year stock price forecast is 104.00% higher than the current stock price, while the lowest is $58 (+40.64%) and the highest is $105 (+154.61%).

Price Target: $84.13 (+104.00%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$58	$84.13	$85	$105
Change	+40.64%	+104.00%	+106.11%	+154.61%

Analyst Ratings

The average analyst rating for Ionis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	12	12	10	10	10	12
Buy	9	8	9	9	9	9
Hold	5	4	4	5	5	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	26	24	23	24	24	25

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Eric Joseph Citi	Citi	Buy Maintains $100	Buy	Maintains	$100	+142.48%	Oct 29, 2026
Gary Nachman Canaccord Genuity	Canaccord Genuity	Buy Maintains $85	Buy	Maintains	$85	+106.11%	Oct 29, 2026
Mitchell Kapoor H.C. Wainwright	H.C. Wainwright	Buy Reiterates $100	Buy	Reiterates	$100	+142.48%	Oct 26, 2026
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Maintains $104	Buy	Maintains	$104	+152.18%	Oct 22, 2026
David Lebowitz BMO Capital	BMO Capital	Buy Upgrades $54 → $66	Buy	Upgrades	$54 → $66	+60.04%	Oct 21, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

922.37M

from 943.71M

-2.26%

from 943.71M

Revenue Next Year

1.36B

from 922.37M

47.44%

from 922.37M

EPS This Year

-2.62

from -1.54

EPS Next Year

-1.15

from -2.62

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	810.46M	587.37M	787.65M	705.14M	943.71M	922.37M
Revenue Growth	11.13%	-27.53%	34.10%	-10.48%	33.83%	-2.26%
Operating Income	-30.19M	-410.19M	-353.73M	-475.08M	-381.68M	-584.34M
Net Income	-28.60M	-269.72M	-366.29M	-453.90M	-381.39M	-579.36M
EPS	-	-	-	-	-1.54	-2.62
Free Cash Flow	-	-	-	-	-320.03M	-533.00M
No. Analysts	-	-	-	-	-	24

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	1.2B
Avg	922.4M
Low	851.8M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	24.7%
Avg	-2.3%
Low	-9.7%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-2.12
Avg	-2.62
Low	-2.99

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-